InvestorsHub Logo
Followers 6
Posts 88
Boards Moderated 0
Alias Born 03/13/2012

Re: Pepsiman2001 post# 53133

Thursday, 01/30/2014 10:28:46 PM

Thursday, January 30, 2014 10:28:46 PM

Post# of 403052
Pepsiman2001 - I think your recollection is pretty accurate from what I recall as well. The end of the company followed closely on the heals of the reverse split too. The research I did also revealed the former CEO (Nicholas Landekic) was not well liked in the industry and he might of alienated potential partners. His replacement, Edward F. Smith, inherited a mess he could not recover from in time. Make no mistake about it though, the purchase of the Polymedix assets including Brilicidin and the defensin-mimetics platform was the heist of all times in my opinion. We purchased a unique, first of it's kind antibiotic where bacterial resistance is unlikely to develop. Efficacy was established in the Phase 2a, the 2b is to further refine the optimal dosage (hopefully single dose). So we bought an antibiotic ready for the phase 2b and possible fast tracking that has a potential market in excess of 1 billion for a mear 5-million. Incredible in my mind and that does not include the other drugs in the Polymedix pipeline. Leo found a gem and got it for fire sale money. Gives me great comfort because it reduces the overall risk for Cellceutix as we wait for additional evidence of what Kevetrin is doing, and from all indications it's going stellar there as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News